Invaio Sciences has acquired Peptyde Bio to bring an established platform and IP portfolio enabling Invaio to speed up the design and discovery of peptides
Peptyde Bio is the first company spun out of the Donald Danforth Plant Science Center by Danforth Technology Company (DTC) , the wholly-owned subsidiary formed by the Danforth Center in February 2022 .